Impact of birth rate, seasonality and transmission rate on minimum levels of coverage needed for rubella vaccination.

C J E Metcalf, J Lessler, P Klepac, F Cutts, B T Grenfell
Author Information
  1. C J E Metcalf: Department of Zoology, Oxford University, Oxford, UK. charlotte.metcalf@zoo.ox.ac.uk

Abstract

Childhood rubella infection in early pregnancy can lead to fetal death or congenital rubella syndrome (CRS) with multiple disabilities. Reduction of transmission via universal vaccination can prevent CRS, but inadequate coverage may increase CRS numbers by increasing the average age at infection. Consequently, many countries do not vaccinate against rubella. The World Health Organization recommends that for safe rubella vaccination, at least 80% coverage of each birth cohort should be sustained. The nonlinear relationship between CRS burden and infection dynamics has been much studied; however, how the complex interaction between epidemic and demographic dynamics affects minimum safe levels of coverage has not been quantitatively evaluated across scales necessary for a global assessment. We modelled 30-year CRS burdens across epidemiological and demographic settings, including the effect of local interruption of transmission via stochastic fadeout. Necessary minimum vaccination coverage increases markedly with birth and transmission rates, independent of amplitude of seasonal fluctuations in transmission. Susceptible build-up in older age groups following local stochastic extinction of rubella increased CRS burden, indicating that spatial context is important. In low birth-rate settings, 80% routine coverage is a conservative guideline, particularly if supplemented with campaigns and vaccination of women of childbearing age. Where birth and transmission rates are high, immunization coverage must be well above 80% and campaigns may be needed. Policy-makers should be aware of the potential negative effect of local extinction of rubella, since heterogeneity in vaccination coverage will shape extinction patterns, potentially increasing CRS burdens.

References

  1. Epidemiol Infect. 2000 Dec;125(3):635-50 [PMID: 11218214]
  2. Epidemiol Infect. 2000 Dec;125(3):617-34 [PMID: 11218213]
  3. Science. 2000 Jan 28;287(5453):667-70 [PMID: 10650003]
  4. Aust Hosp (Syd). 1947 Nov;14(11):7-9 [PMID: 18914301]
  5. Epidemiol Infect. 1998 Dec;121(3):653-71 [PMID: 10030716]
  6. Bull World Health Organ. 1980;58(6):931-5 [PMID: 6971191]
  7. Epidemiol Infect. 2010 Jan;138(1):108-16 [PMID: 19538818]
  8. Infect Control Hosp Epidemiol. 1998 Aug;19(8):570-3 [PMID: 9758057]
  9. Vaccine. 2003 Jun 20;21(21-22):2708-19 [PMID: 12798608]
  10. J R Soc Interface. 2011 Mar 6;8(56):369-76 [PMID: 20659931]
  11. Bull World Health Organ. 2002;80(4):264-70 [PMID: 12075361]
  12. Epidemiol Infect. 2011 Jul;139(7):1029-38 [PMID: 20843389]
  13. Int J Epidemiol. 1980 Mar;9(1):13-23 [PMID: 7419327]
  14. Int J Epidemiol. 1999 Dec;28(6):1176-84 [PMID: 10661666]
  15. Proc Biol Sci. 2009 Jul 7;276(1666):2469-76 [PMID: 19364743]
  16. Wkly Epidemiol Rec. 2011 May 20;86(21):205-20 [PMID: 21608300]
  17. PLoS Med. 2011 Oct;8(10):e1001110 [PMID: 22039353]
  18. Theor Popul Biol. 2012 Dec;82(4):275-82 [PMID: 22178687]
  19. Proc Biol Sci. 2003 Aug 7;270(1524):1573-8 [PMID: 12908977]
  20. Epidemiol Infect. 2000 Jun;124(3):467-79 [PMID: 10982071]
  21. Nature. 2008 Feb 7;451(7179):679-84 [PMID: 18256664]
  22. J Theor Biol. 2003 Jul 7;223(1):19-25 [PMID: 12782113]
  23. Vaccine. 1995 Nov;13(16):1611-6 [PMID: 8578850]
  24. Epidemiol Infect. 2011 Jul;139(7):1039-49 [PMID: 20920382]
  25. J Hyg (Lond). 1983 Apr;90(2):259-325 [PMID: 6833747]
  26. Nature. 1985 Nov 28-Dec 4;318(6044):323-9 [PMID: 3906406]
  27. Epidemiol Infect. 1988 Jun;100(3):419-42 [PMID: 3378585]
  28. J Hyg (Lond). 1985 Oct;95(2):419-36 [PMID: 4067297]

Grants

  1. R01 GM083983/NIGMS NIH HHS
  2. R24 HD047879/NICHD NIH HHS
  3. R01-GM083983-01/NIGMS NIH HHS

MeSH Term

Age Factors
Birth Rate
Child
Child, Preschool
Demography
Female
Global Health
Humans
Immunity, Herd
Infant
Infectious Disease Transmission, Vertical
Mass Vaccination
Models, Biological
Pregnancy
Pregnancy Complications, Infectious
Rubella Syndrome, Congenital
Rubella Vaccine
Rubella virus
Seasons

Chemicals

Rubella Vaccine

Word Cloud

Created with Highcharts 10.0.0coveragerubellaCRStransmissionvaccinationbirthinfectionage80%minimumlocalextinctioncanviamayincreasingsafeburdendynamicsdemographiclevelsacrossburdenssettingseffectstochasticratescampaignsneededrateChildhoodearlypregnancyleadfetaldeathcongenitalsyndromemultipledisabilitiesReductionuniversalpreventinadequateincreasenumbersaverageConsequentlymanycountriesvaccinateWorldHealthOrganizationrecommendsleastcohortsustainednonlinearrelationshipmuchstudiedhowevercomplexinteractionepidemicaffectsquantitativelyevaluatedscalesnecessaryglobalassessmentmodelled30-yearepidemiologicalincludinginterruptionfadeoutNecessaryincreasesmarkedlyindependentamplitudeseasonalfluctuationsSusceptiblebuild-upoldergroupsfollowingincreasedindicatingspatialcontextimportantlowbirth-rateroutineconservativeguidelineparticularlysupplementedwomenchildbearinghighimmunizationmustwellPolicy-makersawarepotentialnegativesinceheterogeneitywillshapepatternspotentiallyImpactseasonality

Similar Articles

Cited By